myIV.com Educates Patients on IV Therapy


First website of its kind provides information and tips on ‘all things IV, simplified’ to inform and empower patients and their family members to be their own healthcare advocates

Hampton, VA – January 23, 2018 – Today marks the start of the #myIVawareness campaign with the official launch of myIV.com, a new resource to empower and inform patients and family members responsible for care on intravenous (IV) therapy. myIV.com, sponsored by ivWatch, is the first online patient resource of its kind providing visitors simplified information about IVs and the symptoms of possible complications.

Nearly 80 percent of all hospital patients receive an IV1, making it the most common invasive medical procedure. Still, close to 50 percent of IVs fail due to complications. Every failure of an IV results in a drug delivery error and carries the potential for reduced drug efficacy and physical harm. Complications range from skin redness, burning, tissue necrosis, limb amputation and even death.

“To have a single location with reliable and relevant information on IVs is filling a large gap in patient education,” said Susan Brown, MSN, RN, Med, VA–BC. “I spent many years educating patients and their families on what an IV was, why it was needed and complication symptoms. To have a site for patients to reference before and during a hospital stay will help facilitate better conversations with healthcare professionals.”

Users of the site have free access to comprehensive educational content including a guide on how to talk to your healthcare professional, definitions of common medical terms, IV FAQs, as well as patient stories.

Caitlin King, myIV.com’s first “Patient Spotlight,” wishes she had access to an IV awareness website when one of her twin daughters experienced IV issues shortly after being born seven weeks premature. King hopes other parents take from her experience the importance of educating themselves when it comes to children and IVs.

“There is no awareness about IVs, it’s not talked about, and yet it happens every day,” said King. “As a parent, helplessness is one of the worst feelings in the world. If there is something you can do when it comes to knowing what to look for, do it.”

To learn more about myIV.com and #myIVawareness, visit www.myIV.com and follow myIV.com on Facebook, Twitter, LinkedIn and Pinterest.

1. Zhang, L., Cao, S., Marsh, N., Ray-Barruel, G., Flynn, J., Larsen, E. and Rickard, C.M. (2016) Infection risks associated with peripheral vascular catheters. Journal of Infection Prevention. 17(5), p.207-213. doi: 10.1177/1757177416655472

About myIV.com
myIV.com is an online patient resource portal dedicated to empowering patients with information related to receiving an IV. As the first website of its kind focused on IVs and IV therapy, myIV.com fills the gap in patient education and makes IVs easier to understand. myIV.com is sponsored by ivWatch. Help raise #myIVawareness on Twitter, Facebook, LinkedIn and Pinterest. For more information, visit www.myIV.com.

###

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Office (757) 224-2606, Mobile (757) 660-4949

In the News: At CES 2018, Digital Health Took Center Stage

ivWatch included in Extremetech.com’s CES healthcare coverage
ivWatch was included in a recent round-up article of the stand-out healthcare devices on display at CES 2018. The ivWatch device was praised as an innovation to enable disruption in the healthcare industry and empower consumers to monitor and manage their health and wellness. The article discusses the problem, symptoms and frequency of IV infiltration events and the application of ivWatch technology to improve patient care.
Read the full article here.

Gary Warren Named Small Business Champion of the Year Finalist

December 14, 2017 – ivWatch announces Gary Warren, President and CEO of ivWatch is among five small business owners competing for the Hatch “Small Business Champion of the Year” award. The winner receiving the most votes will be named and recognized at the fourth annual State of the Startup Community Address on January 25. Voting is simple and open to anyone now through Sunday, Jan. 21 here.

Under Warren’s leadership, ivWatch is on a pursuit to provide affordable and innovative technology allowing hospitals to improve the safety for their patients by reducing the risks associated with IV infiltration.

“Building a medical device company is both a business risk and costlier than most would realize. And it has been an exciting journey to see the growth of ivWatch over the past eight years,” says Warren. “Our employees are united by the common mission to advance patient safety and it’s rewarding to be at a stage where our product is at work in hospitals across the country.”

The State of the Startup Community Address is organized for the Hampton Roads business community to come together and reflect on progress throughout the year. Hampton-based ivWatch may be small with just under 40 employees, but the prospects are promising as personnel has more than doubled in two years. The company has a dedicated executive team and with increased research and development, sales force and marketing teams they are prepared for continued growth and expansion.

“The five finalists all embody the entrepreneurial spirit of our growing small business community,” says Zack Miller, founder of Hatch. “Gary’s a leader in the Hampton Roads business and entrepreneur communities and our members can look to him to see how an idea can become a company, and how passion can make a company competitive and successful.”

To cast a vote for Gary Warren, please visit http://www.startwithhatch.com/ssca/#champ

About Hatch:
Hatch is an award-winning organization that is dedicated to making entrepreneurship a viable option for everyone. Hatch has helped thousands of entrepreneurs start and grow businesses. In addition to providing entrepreneurs with the tools and resources they need individually, Hatch helps cities champion entrepreneurship within their community and prepare for their future economic needs with investments in human capital. Hatch is located in Norfolk, Virginia.

About ivWatch:
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLChttp://www.ivWatch.com

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949

World Pediatric Project adds Gary Warren to Executive Board of Directors

October 25, 2017 – ivWatch announces that Gary Warren, President and CEO of ivWatch, LLC has recently been added to the World Pediatric Project (WPP) Executive Board of Directors. Mr. Warren brings extensive executive experience in developing and managing high-growth technology and venture-backed private companies to the Executive Board.

Mr. Warren and the other members of the WPP Executive Board share a passion for bringing advanced technology to underserved areas. Access to the latest medical devices and technology, combined with the talent and commitment of the WPP volunteer doctors, surgeons, and nurses, allows WPP to help thousands of children each year. As a part of the newly structured executive board, Mr. Warren will help oversee operations and financials of WPP.

“It is an honor to be a part of this well-established organization”, says Gary Warren, ivWatch President & CEO. “My goal is to expand recognition for WPP beyond its current base of supporters. The countries and families served by WPP need access to the type of healthcare and surgery we expect and see as ‘basic’ here in the United States. This access could not be more immediate in many areas WPP serves due to the recent destruction caused by hurricanes and flooding.”

ivWatch supported a surgical mission to St. Vincent and the Grenadines in 2016. The company was able to send a number of its medical devices to be used during and after surgery. The ivWatch Model 400 is a continuous monitoring system that allows clinicians to better manage the risk of IVs by providing early detection of infiltration and extravasation, when fluid leaks outside of the vein.

“We are thrilled to have Gary join our Executive Board of Directors,” says Susan Rickman, CEO of World Pediatric Project. “It’s an exciting time for our organization as we launch and begin to roll out our most recent strategic initiative, Transformation2023. Gary’s experience and insight will help us achieve our goal of healing more children, sooner.”

World Pediatric Project’s Tranformation2023 includes:

  • Accelerating WPP’s effective outreach twice as fast with 3,000 or more children helped 7 years sooner
  • Cumulatively reaching 13,000 children benefiting from 36,000 procedures within 7 years
  • Financial contributions of $45 million delivering $206 million in pediatric specialist care

For more information on World Pediatric Project or to donate, please visit: https://www.worldpediatricproject.org/

About World Pediatric Project
World Pediatric Project is a 501(c)(3) nonprofit organization dedicated to healing critically ill children and building healthcare capacity in the world. Founded in 2001, WPP mobilizes pediatric diagnostic and surgical teams to low resource countries in the Caribbean and Central America and brings children to partner hospitals in the United States for care. For more information, visit worldpediatricproject.org or call 804-282-8830. Like us on Facebook and follow us on Twitter.

MEDIA CONTACT: Jason Kenney, jkenney@worldpediatricproject.org, Office (804)-282-8830

About ivWatch:
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLC. https://www.ivwatch.com/

MEDIA CONTACT: Amara Betoney, amara.betoney@ivwatch.com, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949

In the News

ivWatch Inks Distribution Deal with Terumo
September 29, 2017

ivWatch has recently signed a licensing and distribution agreement with Terumo to improve patient safety, according to a Sept. 21 press release. Terumo will become the exclusive distributor of the ivWatch Model 400 and ivWatch OEM board in Japan. ivWatch technology can be integrated with other patient monitoring systems, infusion pumps and other devices easily with the ivWatch OEM board. The agreement also allows Terumo to exclusively integrate ivWatch into existing and future Terumo products in Japan.
Read the full article here.

ivWatch President and CEO Invited to Judge Pediatric Device Competition

Gary Warren, ivWatch President & CEO, will join the Review Committee of the Atlantic Pediatric Device Consortium (APDC) Pediatric Device Innovation Competition. The Pediatric Device Innovation Competition is a seed grant competition that provides an opportunity for the scientific and business community including entrepreneurs, clinicians, scientists, businesses, academic researchers and medical and engineering graduate and undergraduate students, to develop and commercialize a pediatric medical device. Grants are expected to range from $5,000 to a maximum of $50,000 for one year.

Mr. Warren has extensive executive experience in developing and managing high-growth technology and venture-backed private companies with a focus on product management and delivery in small start-up companies, large public companies, and government programs. For the past seven years, Mr. Warren has been with ivWatch , the market leader in developing, commercializing and distributing non-invasive sensor technology to monitor a patient’s IV site for complications. The company’s flagship product, the ivWatch Model 400, is an FDA-cleared stand-alone continuous monitoring system that allows clinicians to manage the risk of IVs by providing early detection of infiltration and extravasation. Reliable early detection of infiltrations and extravasations, when fluid leaks outside of the vein, is necessary to help hospitals manage the risks associated with this common invasive procedure.

The APDC is an FDA funded consortium based out of Georgia Tech, Emory University, Children’s Healthcare of Atlanta, and Virginia Commonwealth University that provides a national platform to translate medical device ideas from concept to commercialization.  APDC’S mission is to enhance the lives of children through the development of novel pediatric medical devices, which are both safe and effective.  The consortium provides an environment of creativity, where ideas are reviewed, tested, and developed.

As part of the review committee, Mr. Warren will assess the proposals on a number of factors including: 1) clinical significance of the pediatric device, 2) approach to product development, 3) likelihood for marketing success, 4) project team, environment, and resources, and 5) potential for additional funding. Project presentations take place today, Monday, September 25, 2017 on the Virginia Commonwealth University (VCU) campus with notification of awards announced on October 30, 2017.

About APDC
The Atlantic Pediatric Device Consortium (APDC) is one of seven FDA funded pediatric device consortia awarded in 2013.  A collaboration between Georgia Tech, Emory University, Children’s Healthcare of Atlanta and Virginia Commonwealth University, APDC provides a national platform to translate ideas through its product development pathway all the way to commercialization. The mission of APDC is to enhance the lives of children through the development of novel pediatric medical devices, which are both safe and effective. Since 2011 the Consortium has created an environment of creativity, where innovative ideas are reviewed, tested and developed and it reflects the long term commitment of our partner institutions. Success is measured by the development, production and marketing of several novel pediatric medical devices.
http://atlanticpediatricdeviceconsortium.org/projects

About ivWatch
ivWatch, LLC is a medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. ivWatch provides a first-of-its-kind, FDA-cleared, noninvasive medical device that continuously monitors peripheral IVs for infiltration and extravasation events. The ivWatch Model 400 aims to help eliminate patient harm associated with adverse events and to reduce drug delivery errors. The ivWatch OEM Board integrates ivWatch technology into existing products, enabling OEMs to help healthcare providers deliver a higher level of patient care and to reduce risks related to IV therapy.

The ivWatch OEM Board is not an FDA-cleared device. It is the responsibility of the Original Equipment Manufacturer integrating ivWatch technology to secure the proper regulatory clearance. Follow us on Twitter@ivWatch or Facebook @ivWatchLLC.

MEDIA CONTACT: Leah Moore, leah.moore@ivwatch.com, Office (855) 489-2824 x7031, Mobile (757) 839-5653

ivWatch Logo White

Download Our Whitepaper

Thank you for requesting more information about the ivWatch Clinical Studies. The ivWatch Model 400 is the only continuous monitoring device for the early detection of IV infiltration and extravasation events.

[fc id='6'][/fc]

You have Successfully Subscribed!

Pin It on Pinterest